About LieffCabraser

"One of the nation's premier plaintiffs firms," Lieff Cabraser has 120 lawyers in San Francisco, New York, Nashville, and Munich. We have a widely diversified practice successfully representing plaintiffs in the fields of personal injury and mass torts, securities and financial fraud, employment discrimination and unlawful employment practices, product defect, consumer protection, antitrust, environmental and toxic exposures, False Claims Act, digital privacy and data security, and civil and human rights. Our clients include individuals, classes and groups of people, businesses, and public and private entities.

Department of Justice Announces Former Generic Pharmaceutical Executive Pleads Guilty for Role in Criminal Antitrust Conspiracy

Kellum is Fourth Executive to Be Charged in Ongoing Investigation A former senior executive pleaded guilty today for his role in a conspiracy to fix prices, rig bids, and allocate customers for generic drugs, the Department of Justice has announced. According to court documents, from at least March 2013 until at least June 2015, Hector Armando

2020-02-14T13:23:16+00:00February 14th, 2020|Antitrust|

Sarah London Appointed to Plaintiffs’ Executive Committee in Gilead HIV Drug Kidney & Bone Injuries Litigation

On February 5, 2020, Judge Andrew Y.S. Cheng of the Superior Court for the County of San Francisco issued an order appointing Lieff Cabraser partner Sarah R. London  to the Plaintiffs’ Executive Committee in the Gilead HIV Drug Kidney & Bone Injuries Litigation. Sarah will lead the litigation on behalf of patients across California who allege they suffered kidney

2020-02-07T13:06:16+00:00February 7th, 2020|Personal Injury, Prescription Drug Injuries|

Daniel Chiplock Co-Authors Piece in Support of the SEC’s Continued Use of Disgorgement for the Harvard Law School Forum on Corporate Governance

Lieff Cabraser partner Daniel P. Chiplock, along with Tyler Gellasch of the Healthy Markets Association and Andy Green of the Center for American Progress, wrote a piece published by the Harvard Law School Forum on Corporate Governance in support of the Securities & Exchange Commission’s continued ability to compel disgorgement as a remedy in financial

2020-02-03T14:15:52+00:00February 3rd, 2020|Firm News, Securities Fraud|

Johnson & Johnson Ordered to Pay $344 Million for Selling Transvaginal Mesh Implants Despite Known Health Risks

As reported by Law360 (subscription), a California federal judge has ruled that Johnson & Johnson must pay nearly $344 million in civil penalties for misleading consumers about the true health risks associated with its pelvic mesh products. The trailblazing suit was brought by California’s attorney general, Xavier Becerra, who in a statement touting the judge’s

2020-01-31T14:08:29+00:00January 31st, 2020|Personal Injury, Women's Health|

Lieff Cabraser donates goods to Youth Villages of Middle Tennessee

Lieff Cabraser is proud to announce that it has organized an office building-wide drive to collect much-needed household goods for children in need at Youth Villages of Middle Tennessee. The successful drive resulted in the donation of several truckloads of goods including household items, clothing, books, and games. Youth Villages is a national organization that

2020-01-29T12:01:12+00:00January 29th, 2020|Firm News, Public Good|

Lieff Cabraser Announces Notice of Settlement for Anticoagulant Medications Lovenox® and Generic Enoxaparin

If You Bought or Provided Reimbursement for the Anticoagulant Medications Lovenox® or Generic Enoxaparin Between September 21, 2011 and September 30, 2015 You Could Get Money from Class Action Settlements Totaling $120 Million Proposed Settlements totaling $120 million have been reached in a class action lawsuit regarding the price that uninsured consumers, hospitals, and third-party

2020-01-25T07:40:20+00:00January 25th, 2020|Antitrust|